6.4 Neurological Impairment, Anemia of Burn Injury, Coagulopathy, and Musculoskeletal Protection

6.4 Neurological Impairment, Anemia of Burn Injury, Coagulopathy, and Musculoskeletal Protection

Core Knowledge: The systemic reach of major burn trauma extends deeply into the neurological, hematological, and musculoskeletal systems. Clinicians must navigate complex diagnostic challenges—from differentiating burn encephalopathy and toxic inhalants to managing profound burn anemia without over-transfusing blood products. Meticulous positioning, anti-Xa-guided thromboprophylaxis, and early mobilization are vital to prevent lifelong physical disability and fatal thromboembolism.

---

1. Neurological Derangements & Burn Encephalopathy

Central nervous system (CNS) dysfunction in burn critical care ranges from acute confusion and agitation to profound lethargy, seizures, and coma. Thermal injury does not cause direct brain damage unless accompanied by blast trauma, electrical current passage, or severe hypoxia.

                      SPECTRUM OF NEUROLOGICAL IMPAIRMENT IN BURNS
  ┌────────────────────────────────────────────────────────────────────────────────────────┐
  │                              PRIMARY SYSTEMIC DRIVERS                                  │
  ├────────────────────────────────────────────────────────────────────────────────────────┤
  │ [1] TOXIC INHALANTS: Carbon monoxide (COHb) cellular hypoxia & cyanide (HCN) inhibition│
  │     of mitochondrial cytochrome c oxidase ──► Immediate loss of consciousness.         │
  │ [2] BURN ENCEPHALOPATHY: Cytokine-mediated disruption of the blood-brain barrier       │
  │     (TNF-α, IL-1β, IL-6), cerebral edema, microglial activation, and neuroinflammation.│
  │ [3] METABOLIC / ELECTROLYTE CRISES: Rapid sodium fluctuations (cerebral edema vs       │
  │     central pontine myelinolysis), severe hypophosphatemia, and uremic encephalopathy. │
  │ [4] ICU DELIRIUM: Sleep fragmentation, continuous lighting, high-dose continuous opioid│
  │     and benzodiazepine infusions, prolonged mechanical ventilation, and immobility.    │
  └────────────────────────────────────────────────────────────────────────────────────────┘

Delirium Assessment and Non-Pharmacological Bundles

• Screening: Screen all burn ICU patients every shift using validated instruments: the Confusion Assessment Method for the ICU (CAM-ICU) or the Intensive Care Delirium Screening Checklist (ICDSC).
• The ABCDEF Bundle:
  • A (Assess/Manage Pain): Multimodal analgesia (acetaminophen, ketamine, neuropathic agents) to minimize continuous opioid infusions.
  • B (Both SAT and SBT): Daily spontaneous awakening trials and spontaneous breathing trials.
  • C (Choice of Sedation): Targeted light sedation (RASS -1 to 0); prioritize dexmedetomidine or propofol; strictly avoid continuous benzodiazepine infusions (lorazepam, midazolam) which are independent drivers of delirium.
  • D (Delirium Monitoring/Management): Reorient frequently, ensure daylight exposure, minimize nighttime interventions, provide glasses/hearing aids.
  • E (Early Mobility): Passive/active range of motion within 24 hours of admission; out-of-bed mobilization.
  • F (Family Engagement): Involve family members at the bedside to anchor cognitive orientation.

Peripheral Compression Neuropathies

Severe interstitial edema, bulky circumferential dressings, and improper positioning can cause severe peripheral nerve entrapment:

1. Common Peroneal Nerve (Fibular Head): Compression of the lateral knee against bed rails or tight dressings causes foot drop and loss of dorsal foot sensation. Prevention: Pad the lateral fibular head and maintain feet in neutral dorsiflexion ($90^\circ$) using custom splints.
2. Ulnar Nerve (Cubital Tunnel): Sustained elbow flexion ($>90^\circ$) or compression against the armboard compresses the ulnar nerve at the medial epicondyle, causing claw hand deformity and numbness in digits 4 and 5. Prevention: Splint elbows in extension ($0–10^\circ$) or slight functional flexion ($<30^\circ$) with forearm supination.
3. Brachial Plexus: Excessive neck extension/rotation or hyperabduction of the shoulder ($>90^\circ$) stretches the brachial plexus, leading to widespread upper extremity paresis.

---

2. Hematological Alterations: Hemoconcentration to Anemia of Burn Injury

The hematologic response to severe burns undergoes an extreme biphasic transition:

                      HEMATOLOGIC TRAJECTORY ACROSS BURN PHASES
  ┌────────────────────────────────────────┬────────────────────────────────────────┐
  │     RESUSCITATION PHASE (0–24 Hours)   │      FLOW / ACUTE PHASE (Days 2 to 30+)│
  ├────────────────────────────────────────┼────────────────────────────────────────┤
  │ • ACUTE HEMOCONCENTRATION              │ • ANEMIA OF BURN INJURY                │
  │ • Plasma volume leaks into interstitium│ • Microangiopathic thermal hemolysis   │
  │ • Hematocrit spikes to 55% – 65%       │ • Shortened RBC lifespan (30–50% drop) │
  │ • Markedly elevated blood viscosity    │ • Inflammatory marrow suppression      │
  │ • Microvascular stasis & sludging      │ • Massive surgical excision blood loss │
  │ • False normal/high hemoglobin         │ • Hemoglobin drops to 5.0 – 7.0 g/dL   │
  └────────────────────────────────────────┴────────────────────────────────────────┘

Pathophysiology of Anemia of Burn Injury

1. Thermal Microangiopathic Hemolysis: Direct heating of erythrocytes passing through burned dermal capillary beds causes cellular denaturation, spectrin fragmentation, spherocyte formation, and osmotic fragility. Damaged RBCs undergo immediate intravascular lysis or rapid splenic clearance.
2. Shortened RBC Lifespan: Circulating inflammatory mediators, lipid peroxides, and altered erythrocyte membrane deformability shorten the normal 120-day RBC lifespan down to 30 to 40 days.
3. Suppression of Erythropoiesis: Inflammatory cytokines (TNF-α, IL-1β, IL-6, Interferon-gamma) stimulate hepatic hepcidin synthesis, trapping iron inside macrophages and ferritin stores. Concurrently, bone marrow erythroid progenitor cells become resistant to endogenous erythropoietin (EPO).
4. Surgical and Phlebotomy Blood Loss: Tangential excision of extensive burn eschar down to bleeding, viable tissue results in massive blood loss (often 0.5 to 1.0 mL of blood lost per cm² of burn excised). Daily diagnostic laboratory phlebotomy in the ICU further exacerbates blood loss.

Blood Transfusion Strategy: Restrictive vs. Liberal

                    BLOOD TRANSFUSION STRATEGY IN BURN CRITICAL CARE
  ┌────────────────────────────────────────────────────────────────────────────────────────┐
  │                               RESTRICTIVE TRANSFUSION TRIGGER                          │
  │                 (Hemoglobin < 7.0 – 8.0 g/dL / Hematocrit < 21 – 24%)                  │
  ├────────────────────────────────────────────────────────────────────────────────────────┤
  │ • Standard of care in hemodynamically stable burn ICU patients.                         │
  │ • Avoids Transfusion-Related Immunosuppression (TRIM): decreases burn sepsis by >30%.   │
  │ • Decreases Transfusion-Related Acute Lung Injury (TRALI) and circulatory overload (TACO)│
  │ • Transfusion is indicated ONLY if:                                                    │
  │   - Hemoglobin < 7.0 g/dL                                                              │
  │   - Active, uncontrolled intraoperative / wound hemorrhage                            │
  │   - Physiological evidence of tissue hypoxia: ScvO2 < 65%, elevated lactate, or active │
  │     myocardial ischemia (ST-segment changes in pre-existing coronary artery disease)   │
  └────────────────────────────────────────────────────────────────────────────────────────┘

---

3. Burn Coagulopathy & Venous Thromboembolism (VTE) Prophylaxis

Burn trauma triggers profound disruptions in the hemostatic balance, alternating between acute microvascular hypercoagulability and consumption coagulopathy.

                          BURN COAGULOPATHY DYNAMICS
  ┌────────────────────────────────────────────────────────────────────────────────────────┐
  │ Endothelial Thermal Injury & Denudation ──► Massive Tissue Factor (TF) Expression      │
  │                                           │                                            │
  │                                           ▼                                            │
  │  Uncontrolled Thrombin Generation & Platelet Activation ──► Microvascular Thrombosis   │
  │                                           │                                            │
  │                                           ▼                                            │
  │  Depletion of Natural Anticoagulants: Antithrombin III (AT-III), Protein C & Protein S │
  │                                           │                                            │
  │                                           ▼                                            │
  │  Impaired Fibrinolysis (Elevated PAI-1) ──► PERSISTENT PROTHROMBOTIC STATE            │
  │                                           │                                            │
  │                                           ▼                                            │
  │  Consumptive Thrombocytopenia & Clotting Factor Exhaustion during Sepsis / Excision   │
  │                                           │                                            │
  │                                           ▼                                            │
  │                 ACUTE CONSUMPTION COAGULOPATHY & DIFFUSE BLEEDING                      │
  └────────────────────────────────────────────────────────────────────────────────────────┘

Venous Thromboembolism (VTE) Risk and Chemical Prophylaxis

Burn patients meet all three elements of Virchow's Triad:

1. Endothelial Injury: Direct thermal vascular destruction and systemic cytokine inflammation.
2. Hypercoagulability: Depleted Antithrombin III, elevated factor VIII, and circulating microparticles.
3. Venous Stasis: Prolonged bedrest, limb immobilization, and extrinsic edema compression.

Without aggressive thromboprophylaxis, Deep Vein Thrombosis (DVT) and Pulmonary Embolism (PE) occur in up to 25% to 30% of extensive burn patients.

Anti-Xa Guided Thromboprophylaxis Protocol:

• Pharmacological Agent: Low-Molecular-Weight Heparin (LMWH - Enoxaparin) is strongly preferred over unfractionated heparin.
• Burn Pharmacokinetic Challenge: Due to massive third-spacing, hyperdynamic renal clearance (GFR $>150\text{ mL/min}$), and altered volume of distribution, standard fixed-dose enoxaparin (e.g., 30 mg SC q12h or 40 mg daily) frequently results in subtherapeutic anticoagulation.
• Anti-Xa Monitoring: Measure peak anti-Xa levels exactly 4 hours after the third or fourth dose:
  • Target Prophylactic Anti-Xa Range: 0.2 to 0.4 IU/mL (or 0.3–0.5 IU/mL in high-risk centers).
  • Titrate enoxaparin dosage upward (often requiring 40–60 mg SC q12h) to achieve target levels.
• Mechanical Compression: Intermittent pneumatic compression (IPC) devices and graduated compression stockings must be applied continuously to all unburned extremities.

---

4. Musculoskeletal Protection & Heterotopic Ossification (HO)

Major burn injuries place the musculoskeletal system under severe stress through hypermetabolic muscle catabolism, fibrotic contractures, and abnormal bone formation.

                         HETEROTOPIC OSSIFICATION (HO) IN BURNS
  ┌────────────────────────────────────────────────────────────────────────────────────────┐
  │ Pathophysiology: Abnormal formation of mature, lamellar trabecular bone in periarticular│
  │ soft tissues and joint capsules (NOT within the joint space itself).                   │
  │ Driven by: Severe hypercalcemia/hyperphosphatemia flux, local tissue hypoxia, prolonged │
  │ immobilization, and osteogenic cytokine cascades (BMP-2, BMP-4, TGF-β).               │
  ├────────────────────────────────────────────────────────────────────────────────────────┤
  │ MOST COMMON SITES:                                                                     │
  │ 1. Elbow (Postero-medial aspect) — Most frequent (>60% of all burn HO cases)           │
  │ 2. Hip (Anterior / Posterior capsular spaces)                                          │
  │ 3. Shoulder (Subacromial / Glenohumeral spaces)                                        │
  ├────────────────────────────────────────────────────────────────────────────────────────┤
  │ CLINICAL PRESENTATION:                                                                 │
  │ • Sudden, unexplained loss of joint range of motion (ROM) with a hard, "bony" end-feel│
  │ • Localized periarticular warmth, erythema, swelling, and severe focal pain            │
  │ • Ulnar nerve compression neuropathy (frequently associated with medial elbow HO)      │
  ├────────────────────────────────────────────────────────────────────────────────────────┤
  │ DIAGNOSIS & MANAGEMENT:                                                                │
  │ • Serum Alkaline Phosphatase (ALP): Markedly elevated (early biochemical marker).      │
  │ • Imaging: Plain radiographs (late finding, 3–6 weeks); 3D CT scan (definitive map).  │
  │ • Conservative Nursing Management: Gentle, active/active-assisted ROM within pain-free │
  │   limits; NEVER perform forceful, aggressive passive manipulation (causes micro-tears  │
  │   and accelerates bone formation).                                                     │
  │ • Definitive Treatment: Surgical excision of mature ectopic bone after wound healing.  │
  └────────────────────────────────────────────────────────────────────────────────────────┘

Anti-Deformity Positioning Principles